Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025

摘要

This report describes CDC’s recommendation for use of clesrovimab for prevention of severe respiratory syncytial virus (RSV) in infants.

This report describes CDC’s recommendation for use of clesrovimab for prevention of severe respiratory syncytial virus (RSV) in infants.

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

萃取時間: 2026-02-05T15:09:01Z 資料來源: CDC MMWR